These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8838369

  • 1. An immunohistochemical analysis of mdr-1 and bcl-2 expressions in neuroblastoma.
    Kim CJ, Lee YA, Ahn HS, Yun CK, Kim CW, Chi JG.
    Pathol Res Pract; 1995 Oct; 191(10):1010-5. PubMed ID: 8838369
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
    Krajewski S, Chatten J, Hanada M, Reed JC.
    Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
    [Abstract] [Full Text] [Related]

  • 3. Glutathione S-transferase and P-glycoprotein expressions in neuroblastoma.
    Kutlik MT, Ayhan A, Göğüş S, Yalçin B, Cağlar M, Büyükpamukçu M.
    Pediatr Hematol Oncol; 2002 Jan; 19(5):337-45. PubMed ID: 12078865
    [Abstract] [Full Text] [Related]

  • 4. Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma.
    Dhooge CR, De Moerloose BM, Benoit YC, Van Roy N, Philippé, Laureys GG.
    Cancer; 1997 Oct 01; 80(7):1250-7. PubMed ID: 9317175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
    Wuchter C, Karawajew L, Ruppert V, Schrappe M, Harbott J, Ratei R, Dörken B, Ludwig WD.
    Br J Haematol; 2000 Jul 01; 110(1):154-60. PubMed ID: 10930993
    [Abstract] [Full Text] [Related]

  • 10. Bcl-2 expression in neuroblastoma is differentially regulated by differentiation inducers.
    Kim CJ, Kim HO, Choe YJ, Lee YA, Kim CW.
    Anticancer Res; 1995 Jul 01; 15(5B):1997-2000. PubMed ID: 8572591
    [Abstract] [Full Text] [Related]

  • 11. In vivo imaging and specific targeting of P-glycoprotein expression in multidrug resistant nude mice xenografts with [125I]MRK-16 monoclonal antibody.
    Scott AM, Rosa E, Mehta BM, Divgi CR, Finn RD, Biedler JL, Tsuruo T, Kalaigian H, Larson SM.
    Nucl Med Biol; 1995 May 01; 22(4):497-504. PubMed ID: 7550027
    [Abstract] [Full Text] [Related]

  • 12. Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.
    Charpin C, Garcia S, Bouvier C, Devictor B, Andrac L, Lavaut MN, Allasia C.
    Br J Cancer; 1997 May 01; 76(3):340-6. PubMed ID: 9252201
    [Abstract] [Full Text] [Related]

  • 13. Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma.
    Mejía C, Navarro S, Colamonici OR, Pellín A, Castel V, Llombart-Bosch A.
    Oncol Rep; 1999 May 01; 6(1):149-53. PubMed ID: 9864419
    [Abstract] [Full Text] [Related]

  • 14. Activity of iodine-123 metaiodobenzylguanidine in childhood neuroblastoma: lack of relation to tumour differentiation in vivo.
    Brans B, Laureys G, Schelfhout V, Wiele CV, Potter CR, Dhooge C, Simons M, Dierckx RA.
    Eur J Nucl Med; 1998 Feb 01; 25(2):144-9. PubMed ID: 9473262
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
    Wuchter C, Karawajew L, Ruppert V, Büchner T, Schoch C, Haferlach T, Ratei R, Dörken B, Ludwig WD.
    Leukemia; 1999 Dec 01; 13(12):1943-53. PubMed ID: 10602414
    [Abstract] [Full Text] [Related]

  • 16. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K, Fujioka T, Kitagawa H, Takakuwa T, Yamate N.
    Jpn J Clin Oncol; 1993 Jun 01; 23(3):149-55. PubMed ID: 8350488
    [Abstract] [Full Text] [Related]

  • 17. Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells.
    Pituch-Noworolska A, Zaremba M, Wieczorek A.
    Pol J Pathol; 2009 Jun 01; 60(4):168-73. PubMed ID: 20072950
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis and reversal of multidrug resistance in paediatric cancers.
    Chan HS, Grogan TM, DeBoer G, Haddad G, Gallie BL, Ling V.
    Eur J Cancer; 1996 Jun 01; 32A(6):1051-61. PubMed ID: 8763347
    [No Abstract] [Full Text] [Related]

  • 19. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma.
    Ikeda H, Hirato J, Akami M, Matsuyama S, Suzuki N, Takahashi A, Kuroiwa M.
    J Pediatr Surg; 1995 Jun 01; 30(6):805-8. PubMed ID: 7666311
    [Abstract] [Full Text] [Related]

  • 20. A new mdr-1 encoded P-170 specific monoclonal antibody: (6/1C) on paraffin wax embedded tissue without pretreatment of sections.
    Moran E, Larkin A, Doherty G, Kelehan P, Kennedy S, Clynes M.
    J Clin Pathol; 1997 Jun 01; 50(6):465-71. PubMed ID: 9378810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.